EFFECT OF DOXORUBICIN AND 4'-EPIDOXORUBICIN ON MOUSE SPERMATOGENESIS

被引:40
作者
HACKERKLOM, UB
MEISTRICH, ML
GOHDE, W
机构
[1] UNIV MUNSTER, RADIOL KLIN, KLIN STRAHLENBIOL ABT, HITTORFSTR 15-17, D-4400 MUNSTER, FED REP GER
[2] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, DEPT EXPTL RADIOTHERAPY, HOUSTON, TX 77030 USA
来源
MUTATION RESEARCH | 1986年 / 160卷 / 01期
关键词
D O I
10.1016/S0027-5107(96)90007-X
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Flow cytometric and histological analysis, measurements of testicular weight and sperm head counts were performed to analyze the effects of doxorubicin (DX) and 4''-epi-doxorubicin (4''-epi-DX), two closely related antineoplastic agents, on mouse spermatogenesis. The DNA distribution patterns obtained by flow cytometry indicate the frequency of different germ cell types: elongated and round spermatids, primary spermatocytes with a 4 c DNA content, and S-phase spermatogonia and spermatocytes. Following the injection of different doses of DX, characteristic changes of the frequencies of those germ cell types are observed with time, indicating selective inactivation of spermatogonia followed by sequential depletion of spermatocytes, round spermatids, and elongated spermatids, and then recovery of these cells types. Similar changes were observed with 4''-epi-DX; the dose-response curves indicated that 4''-epi-DX might be slightly, although not significantly, less effective than DX. The mutagenic potential of DX and 4''-epi-DX is reflected by an increase of the coefficient of variation in the DNA histogram as a measure of aneuploidy, and an increase of diploid spermatids. Flow cytometric analysis of spermatogenesis offers a sensitive in vivo system to monitor mutagenic agents.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 37 条
[1]   INDUCTION OF SISTER-CHROMATID EXCHANGES BY CHEMOTHERAPEUTIC DRUGS IN SPERMATOGONIA OF MICE - EFFECTS OF PROCARBAZINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE AND MITOMYCIN-C [J].
ABRAHAM, SK ;
FRANZ, J .
MUTATION RESEARCH, 1983, 108 (1-3) :373-381
[2]   MOUSE SPERMATOGONIA AND SPERMATOCYTE SENSITIVITY TO CHEMICAL MUTAGENS [J].
ADLER, ID .
CYTOGENETICS AND CELL GENETICS, 1982, 33 (1-2) :95-100
[3]   SYNTHESIS AND ANTITUMOR PROPERTIES OF NEW GLYCOSIDES OF DAUNOMYCINONE AND ADRIAMYCINONE [J].
ARCAMONE, F ;
PENCO, S ;
VIGEVANI, A ;
REDAELLI, S ;
FRANCHI, G ;
DIMARCO, A ;
CASAZZA, AM ;
DASDIA, T ;
FORMELLI, F ;
NECCO, A ;
SORANZO, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (07) :703-707
[4]   THE GENOTOXIC EFFECTS OF ADRIAMYCIN IN SOMATIC AND GERMINAL CELLS OF THE MOUSE [J].
AU, WW ;
HSU, TC .
MUTATION RESEARCH, 1980, 79 (04) :351-361
[5]   CHRONIC TOXICITY OF ADRIAMYCIN - NEW ANTINEOPLASTIC ANTIBIOTIC [J].
BERTAZZOLI, C ;
FERNI, G ;
SOLCIA, E ;
RICEVUTI, G ;
CHIELI, T .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1972, 21 (03) :287-+
[6]  
DACUNHA MF, 1983, J UROLOGY, V130, P927
[7]   CHANGES OF ACTIVITY OF DAUNORUBICIN, ADRIAMYCIN AND STEREOISOMERS FOLLOWING INTRODUCTION OR REMOVAL OF HYDROXYL-GROUPS IN AMINO SUGAR MOIETY [J].
DIMARCO, A ;
CASAZZA, AM ;
DASDIA, T ;
NECCO, A ;
PRATESI, G ;
RIVOLTA, P ;
VELCICH, A ;
ZACCARA, A ;
ZUNINO, F .
CHEMICO-BIOLOGICAL INTERACTIONS, 1977, 19 (03) :291-302
[8]   INTERACTION OF SOME DAUNOMYCIN DERIVATIVES WITH DEOXYRIBONUCLEIC ACID AND THEIR BIOLOGICAL ACTIVITY [J].
DIMARCO, A ;
ZUNINO, F ;
SILVESTR.R ;
GAMBARUCCI, C ;
GAMBETTA, RA .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (06) :1323-+
[9]   CRITICAL-APPRAISAL OF THE MOUSE TESTICULAR DNA-SYNTHESIS INHIBITION TEST FOR THE DETECTION OF MUTAGENS AND CARCINOGENS [J].
DONATSCH, P ;
GURTLER, J ;
MATTER, BE .
MUTATION RESEARCH, 1982, 92 (1-2) :265-273
[10]   INHIBITION OF MOUSE TESTICULAR DNA-SYNTHESIS BY MUTAGENS AND CARCINOGENS AS A POTENTIAL SIMPLE MAMMALIAN ASSAY FOR MUTAGENESIS [J].
FRIEDMAN, MA ;
STAUB, J .
MUTATION RESEARCH, 1976, 37 (01) :67-76